Blood breakdown product, hemin, was used to induce cell death in primary cortical neurons. For the protective studies, cells were treated with hemin (100 μM) in the presence of NAC (0.01–1.00mM), Trolox (0.1–100.0 μM), α‐lipoic acid (0.01–2.00mM), U 73122 (0.1–100.0 μM), β carotene (0.1–100.0 μM), MS‐PPOH (0.1–100.0 μM), aspirin (0.1–100.0 μM), celecoxib (0.1–100.0 μM), Indomethacin (0.1–100.0 μM), Zileuton (0.1–100.0 μM), BW B70 (0.1–100.0 μM), BW A4C (0.1–100.0 μM), NCTT‐956 (0.1–100.0 μM), PD146176 (0.1–100.0 μM), MK 561 (0.1–100.0 μM), glutathione ethyl ester (1–10mM), L‐oxothiazolidine‐4‐carboxylate (1–10mM), cystamine (0.1–10.0 μM), and nordihydroguaiaretic acid (0.1–10.0 μM). Cell viability was analyzed 24 hours after treatment. Cells were rinsed with warm phosphate‐buffered saline (PBS) and assessed by methyl thiazolyl tetrazolium (MTT) assay. The fidelity of MTT assays in measuring viability was verified by calcein‐AM/ethidium homodimer‐1 staining (Live/Dead assay; Molecular Probes, Eugene, OR), following the manufacturer's instructions.